DEVELOPING THE FRAMEWORK FOR FIRST-IN-CLASS IMMUNOTHERAPIES THAT TARGET DISSEMINATED TUMOR CELLS AND PREVENT BREAST CANCER METASTASIS
$2,638,764FY2020Defense Health AgencyDOD
Fred Hutchinson Cancer Center, Seattle WA
Fred Hutchinson Cancer Center, Seattle WA